Africa CDC and GAFFI to launch Continental Report on Diagnostics for Fungal Diseases in Africa at CPHIA 2022


WHAT: Africa Centres for Disease Control and Prevention (Africa CDC) and Global Action for Fungal Infections (GAFFI) launch Report on Diagnostics for fungal diseases in Africa

WHEN: 12 December, 2022

TIME: 18:00 – 20:00 (UTC+2)

WHERE: 2nd International Conference on Public Health in Africa (CPHIA 2022), Kigali Convention Centre, Kigali, Rwanda

WHY: Fungal infections kill nearly 50% of AIDS patients, many cancer, and intensive patients, exacerbate asthma and COPD and cause blindness through fungal keratitis. Africa CDC and GAFFI will present 2022 survey data from 48 African countries on diagnostic availability and a pilot program in Guatemala that reduced mortality in 2 years by 8% simply with improved rapid diagnostics. The major report will be launched at the event.

About CPHIA 2022

The formal programme takes place 13-15 December 2022 in Kigali Convention Centre, Kigali, Rwanda. Official Side Events begin on 12 December.

The 2nd International Conference on Public Health in Africa (CPHIA 2022) is a three-day conference that will provide a unique platform for African researchers, policymakers, and stakeholders to come together and share perspectives and research findings in public health while ushering in a new era of strengthened scientific collaboration and innovation across the continent.

Conference theme: Preparedness for future Pandemic and Post-Pandemic Recovery: Africa at a Crossroad.

About the Africa Centres for Disease Control and Prevention (Africa CDC)

Africa CDC is a specialized technical institution of the African Union that strengthens the capacity and capability of Africa’s public health institutions and partnerships to detect and respond quickly and effectively to disease threats and outbreaks based on data-driven interventions and programs. For more information, please visit:

About Global Action for Fungal Infections (GAFFI)

The high-level objective of GAFFI is to ensure that WHO Essential Diagnostics and Antifungal drugs are accessible to all and aligned to Universal Health Coverage. Vulnerable people from countries in the global south are disproportionately affected, and those afflicted with fungal disease live in misery due to morbidity, the inability to work, and the stigma. Limited diagnosis and poor measurement of disease morbidity means that the true scale of the problem is unknown. GAFFI has been a key global voice for fungal diseases in terms of public and global health since 2013.

Journalists are invited to join the virtual meeting here: Click here

For media inquiries, please contact:

Ms. Liliane Bilogho Ndong Nang | Advocacy/Communications Officer | Africa CDC | E-mail: | Libreville, Gabon

Ms. Maya Yglesias| Public relations | GAFFI | E-mail: | London, England Division of Policy, Health Diplomacy, and Communication, Africa CDC, African Union Commission | E-mail: | Web: | Addis Ababa, Ethiopia | Follow us: Facebook | Twitter | Youtube | Linkedin



English, French